Schonfeld Strategic Advisors LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$508,355
-35.1%
102,285
-17.8%
0.00%
-42.9%
Q4 2022$783,105
-72.5%
124,500
-52.8%
0.01%
-70.8%
Q3 2022$2,851,000
+111.2%
263,891
+122.9%
0.02%
+84.6%
Q2 2022$1,350,000
+84.4%
118,400
+47.3%
0.01%
+85.7%
Q1 2022$732,000
-29.6%
80,400
+98.5%
0.01%
-36.4%
Q3 2021$1,040,000
-61.8%
40,500
-61.2%
0.01%
-62.1%
Q2 2021$2,719,000
+910.8%
104,279
+942.8%
0.03%
+190.0%
Q4 2018$269,00010,0000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders